Successful second transplantation with non-myeloablative conditioning using haploidentical donors for young patients after graft failure following double umbilical cord cell transplantation

Pediatric Transplantation

Volumn 14, Issue 4, 2010, Pages 465-470

  Liu, Huilan ^a   Wang, Xingbing ^a   Geng, Liangquan ^a   Tang, Baolin ^a   Tong, Juan ^a   Yao, Wen ^a   Wang, Zuyi ^a   Sun, Zimin ^a  

^a ANHUI PROVINCIAL HOSPITAL   (China)

Author keywords

Graft failure; Haploidentical donor; Non myeloablative conditioning; Second transplant

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; ANTIBIOTIC AGENT; BUSULFAN; CARMUSTINE; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; FLUDARABINE; FOSCARNET; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE; METHYLPREDNISOLONE; METRONIDAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TACROLIMUS; THYMOCYTE ANTIBODY; VORICONAZOLE; MYELOABLATIVE AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; APLASTIC ANEMIA; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOMEGALOVIRUS INFECTION; CYTOPENIA; DONOR; DRUG DOSE REDUCTION; DRUG TOLERABILITY; ENGRAFTMENT; EVENT FREE SURVIVAL; FEBRILE NEUTROPENIA; FEMALE; FEVER; GRAFT FAILURE; GRAFT INFECTION; GRAFT VERSUS HOST REACTION; HAPLOIDY; HUMAN; LEUKEMIA; MALE; MUCOSA INFLAMMATION; MYELODYSPLASTIC SYNDROME; NEUTROPHIL ENGRAFTMENT; NONMYELOABLATIVE CONDITIONING; OPERATION DURATION; OPPORTUNISTIC INFECTION; OUTCOME ASSESSMENT; PLATELET ENGRAFTMENT; RADIATION DOSE; SCHOOL CHILD; SEPTIC SHOCK; STEM CELL MOBILIZATION; SYSTEMIC MYCOSIS; WHOLE BODY RADIATION; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HEMATOLOGIC DISEASES; HISTOCOMPATIBILITY; IMMUNOSUPPRESSIVE TREATMENT; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATIONS; PROCEDURES; REOPERATION; RISK FACTOR; TIME; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; CHILD; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOLOGIC DISEASES; HISTOCOMPATIBILITY; HUMANS; MALE; MYELOABLATIVE AGONISTS; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATIONS; REOPERATION; RISK FACTORS; TIME FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION IMMUNOLOGY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77952267500     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2009.01231.x     Document Type: Article

References (18)

1. Laughlin MJ, Barker J, Bambach B, et al. Hematopoietic engraftment and survival in adult recipients of umbilical cord blood from unrelated donors. N Engl J Med 2001 : 344 : 1815 1822.
2. Wagner JE, Barker JN, Defor TE, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: Influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002 : 100 : 1611 1618.
3. Evans PC, Lambert N, Maloney S, Furst DE, Moore JM, Nelson JL. Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma. Blood 1999 : 93 : 2033 2037.
4. Ochiai N, Shimazaki C, Fuchida S, et al. Successful non-T cell-depleted HLA haplo-identical three-loci mismatched hematopoietic stem cell transplantation from mother to son based on the feto-maternal microchimerism in chronic myelogenous leukemia. Bone Marrow Transplant 2002 : 30 : 793 796.
5. Shimazaki C, Ochiai N, Uchida R, et al. Non-T-cell-depleted HLA haploidentical stem cell transplantation in advanced hematologic malignancies based on the feto-maternal michrochimerism. Blood 2003 : 101 : 3334 3336.
6. Wolf SN. Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation. Bone Marrow Transplant 2002 : 29 : 545 552.
7. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974 : 18 : 295 304.
8. Lang P, Mueller I, Greil J, et al. Retransplantation with stem cells from mismatched related donors after graft rejection in pediatric patients. Blood Cells Mol Dis 2008 : 40 : 33 39.
9. Jaing TH, Hung IJ, Yang CP, Tsai MH, Lee WI, Sun CF. Second transplant with two unrelated cord blood units for early graft failure after haematopoietic stem cell transplantation. Br J Haematol 2007 : 137 : 248 251.
10. Jaing TH, Sun CF, Lee WI, Wen YC, Yang CP, Hung IJ. Successful unmanipulated peripheral blood progenitor cell transplantation from an HLA haploidentical 2-locus-mismatched mother in a thalassemic patient with primary graft failure after transplantation of bone marrow and cord blood from unrelated donors. Pediatr Transplant 2008 : 12 : 232 234.
11. Guardiola P, Kuentz M, Garban F, et al. Second early allogeneic stem cell transplantation for graft failure in acute leukemia, chronic myeloid leukemia and aplastic anemia. Br J Haematol 2000 : 111 : 292 302.
12. Slavin S, Nagler A, Naparstek E, et al. Non myeloablative stem cell transplantation and cell therapy as an alternative to coventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematological diseases. Blood 1998 : 91 : 756 763.
13. Rzepecki P, Sarosiek T, Szczylik C. Alemtuzumab, fludarabine and melphalan as a conditioning therapy in severe aplastic anemia and hypoplastic myelodysplastic syndrome - single center experience. Jpn J Clin Oncol 2006 : 36 : 46 49.
14. Chewning JH, Castro-Malaspina H, Jakubowski A, et al. Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure. Biol Blood Marrow Transplant 2007 : 13 : 1313 1323.
15. George B, Mathews V, Viswabandya A, Kavitha ML, Srivastava A, Chandy M. Fludarabine based reduced intensity conditioning regimens in children undergoing allogeneic stem cell transplantation for severe aplastic anemia. Pediatr Transplant 2008 : 12 : 14 19.
16. Jabbour E, Rondon G, Anderlini P, et al. Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantation. Bone Marrow Transplant 2007 : 40 : 431 435.
17. Lu DP, Dong L, Wu T, et al. Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation. Blood 2006 : 107 : 3065 3073.
18. Mccann SR, Bacigalupo A, Gluckman E, et al. Graft rejection and second marrow transplants for acquired aplastic anemia: A report from the Aplastic Anemia Working Party of the European Marrow Transplant Group. Bone Marrow Transplant 1994 : 13 : 233 237.